![]() |
市场调查报告书
商品编码
1831984
血红素检测市场报告,按产品类型(试剂和耗材、设备)、技术(色谱法、免疫测定法等)、最终用户(实验室、医院、研究中心)和地区划分,2025 年至 2033 年Hemoglobin Testing Market Report by Product Type (Reagents and Consumables, Equipment), Technology (Chromatography, Immunoassay, and Others), End-User (Laboratories, Hospitals, Research Centers), and Region 2025-2033 |
2024年,全球血红素检测市场规模达25.5亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到41.2亿美元,2025-2033年期间的复合年增长率(CAGR)为5.22%。糖尿病和贫血等慢性病的发生率上升正在刺激市场发展。
即时检验需求不断成长
向即时检测 (POCT) 的转变是血红蛋白监测市场的重大发展,因为它可以在传统实验室之外提供快速且方便的检测。便携式分析仪可快速提供结果,从而改善患者护理和决策。 2024 年 6 月,堀场製作所推出了新型紧凑型血液学分析仪,包括 Yumizen H550E(自动进样器)、H500E CT(闭管式)和 Yumizen H500E OT(开管式)。这些分析仪可在 60 秒内提供全血 CBC/DIFF 和 ESR 结果的联合检测。
人工智慧(AI)在诊断中的应用日益广泛
血红蛋白检测市场正在探索人工智慧(AI),该技术正迅速应用于血红蛋白检测,以提高准确性和效率。人工智慧系统可以快速评估大数据集,最大限度地减少人为错误,提高诊断准确性。这是血红蛋白检测市场的驱动因素之一。 2024年8月,印度理工学院(IIT)卡拉格普尔分校与萨蒂亚赛医院(Sathya Sai Hospital)合作进行人工智慧贫血筛检。此次合作旨在开发创新解决方案,以应对弱势群体面临的贫血挑战。
提高对贫血的认识与筛检
贫血是一种与低血红素水平相关的疾病,其早期识别正变得越来越重要。世界各国政府和卫生组织正在启动筛检项目,以识别易感人群(例如孕妇和儿童)的贫血。 2024年2月,印度儿科学会(IAP)发起了一项全国性活动,以提高人们对贫血和其他重要儿童健康问题的认识。
The global hemoglobin testing market size reached USD 2.55 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.12 Billion by 2033, exhibiting a growth rate (CAGR) of 5.22% during 2025-2033. An increase in chronic conditions, including diabetes and anemia, is stimulating the market.
Rising Demand for Point-of-Care Testing
The shift to point-of-care testing (POCT) is a significant development in the hemoglobin monitoring market as it provides quick, convenient testing outside of traditional labs. Portable analyzers deliver quick results, which improves patient care and decision-making. In June 2024, Horiba launched new compact hematology analyzers, namely, Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube). They offer combined testing for CBC/DIFF with ESR results from whole blood in 60 seconds.
Growing Use of Artificial Intelligence (AI) in Diagnostics
The hemoglobin testing market overview is exploring AI, which is rapidly being used in hemoglobin testing to improve accuracy and efficiency. AI-powered systems can swiftly evaluate big datasets, minimizing human error and improving diagnosis accuracy. This is one of the hemoglobin testing market drivers. In August 2024, IIT Kharagpur collaborated with Sathya Sai Hospital for AI-powered anemia screening. This joint effort focuses on developing innovative solutions to address the challenges of anemia in underprivileged populations.
Increasing Awareness and Screening for Anemia
Early identification of anemia, a disorder associated with low hemoglobin levels, is becoming increasingly important. Governments and health organizations around the world are launching screening programs to identify anemia in susceptible populations, such as pregnant women and children. In February 2024, the Indian Academy of Pediatrics (IAP) launched a nationwide campaign to raise awareness about anemia and other crucial child health issues.
As per the hemoglobin testing market share analysis, reagents and consumables, such as test strips and other disposable materials, have a strong presence in the market due to their widespread use in diagnostic procedures. The equipment segment, which includes analyzers and point-of-care devices, is experiencing considerable growth due to technical developments and rising demand for portable testing solutions.
Chromatography is frequently utilized for precise and thorough hemoglobin variant analysis, especially in laboratory settings where precision is crucial. Meanwhile, immunoassay technology is gaining popularity because of its speed and cost-effectiveness, making it ideal for point-of-care testing and routine hemoglobin monitoring in a variety of healthcare settings. These segments are contributing to shaping hemoglobin testing market dynamics.
According to the hemoglobin testing industry statistics, laboratories hold a considerable proportion due to their ability to do high-volume testing and extensive analysis. Hospitals play an important role in hemoglobin testing for patient diagnosis and monitoring. Moreover, research institutions contribute to market growth by developing new testing methods and diagnostic technologies.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
As per the hemoglobin testing market outlook, advanced healthcare systems and extensive diagnostic tool usage are pushing the market in North America. Europe benefits from strong government healthcare assistance and heightened awareness of early detection. Asia Pacific is experiencing rapid growth due to its large population, rising healthcare awareness, and improving medical infrastructure. In Latin America, the market is growing as healthcare systems improve and focus on malnutrition-related illnesses. The Middle East and Africa region is evolving, with more access to healthcare, increased investment in diagnostics, and initiatives to tackle regional health challenges such as anemia.